Guava IX is a modern, hybrid-indica strain bred from Stardawg. Its exact origins and the identities of any additional parentage remain undocumented, and breeders have not publicly verified the specifics of its cultivation history. Due to this lack of documentation, its developmental timeline remains obscured, leaving the strain’s precise lineage incomplete within the broader cannabis catalogue.

The terpene profile of Guava IX is headlined by caryophyllene, followed by limonene, humulene, and myrcene, with further contributions from bisabolol, linalool, beta-pinene, and pinene. Sensory experiences with this strain often reflect this complex chemical composition, though specific tasting notes remain an estimation based on these lab-confirmed constituents. The cannabinoid content is noted as THC-dominant, with an estimated THC concentration of 28.5 percent and negligible levels of CBD and CBG.

Guava IX presents a balanced experience for users, providing effects that are both relaxed and focused. These qualities make it a practical choice for managing pain, stress, and sleep. The strain is suitable for cultivation in both indoor and outdoor environments, requiring a moderate level of grower expertise to reach its high yield potential over a 60-day flowering period. Currently, there are no notable offspring recorded for this variety.